Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

M Willis, O Pearson, Zsolt Illés, C Nielsen, Tobias Sejbæk Mathiesen, Martin Duddy, K Petheram, C van Munster, J Killestein, B Uitdehaag, C Malmestrom, E Tallantyre, N Robertson

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

OriginalsprogEngelsk
Publikationsdato14. sep. 2016
StatusUdgivet - 14. sep. 2016
Begivenhed32nd ECTRIMS: Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ExCeL London, London, Storbritannien
Varighed: 14. sep. 201617. sep. 2016

Konference

Konference32nd ECTRIMS
LokationExCeL London
LandStorbritannien
ByLondon
Periode14/09/201617/09/2016

Citer dette

Willis, M., Pearson, O., Illés, Z., Nielsen, C., Mathiesen, T. S., Duddy, M., ... Robertson, N. (2016). Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. Poster session præsenteret på 32nd ECTRIMS, London, Storbritannien.
Willis, M ; Pearson, O ; Illés, Zsolt ; Nielsen, C ; Mathiesen, Tobias Sejbæk ; Duddy, Martin ; Petheram, K ; van Munster, C ; Killestein, J ; Uitdehaag, B ; Malmestrom, C ; Tallantyre, E ; Robertson, N. / Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. Poster session præsenteret på 32nd ECTRIMS, London, Storbritannien.
@conference{4dba586009694181b43616eacf287fcf,
title = "Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab",
author = "M Willis and O Pearson and Zsolt Ill{\'e}s and C Nielsen and Mathiesen, {Tobias Sejb{\ae}k} and Martin Duddy and K Petheram and {van Munster}, C and J Killestein and B Uitdehaag and C Malmestrom and E Tallantyre and N Robertson",
year = "2016",
month = "9",
day = "14",
language = "English",
note = "null ; Conference date: 14-09-2016 Through 17-09-2016",

}

Willis, M, Pearson, O, Illés, Z, Nielsen, C, Mathiesen, TS, Duddy, M, Petheram, K, van Munster, C, Killestein, J, Uitdehaag, B, Malmestrom, C, Tallantyre, E & Robertson, N 2016, 'Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab', 32nd ECTRIMS, London, Storbritannien, 14/09/2016 - 17/09/2016.

Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. / Willis, M; Pearson, O; Illés, Zsolt; Nielsen, C; Mathiesen, Tobias Sejbæk ; Duddy, Martin; Petheram, K; van Munster, C; Killestein, J; Uitdehaag, B; Malmestrom, C; Tallantyre, E; Robertson, N.

2016. Poster session præsenteret på 32nd ECTRIMS, London, Storbritannien.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskning

TY - CONF

T1 - Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab

AU - Willis, M

AU - Pearson, O

AU - Illés, Zsolt

AU - Nielsen, C

AU - Mathiesen, Tobias Sejbæk

AU - Duddy, Martin

AU - Petheram, K

AU - van Munster, C

AU - Killestein, J

AU - Uitdehaag, B

AU - Malmestrom, C

AU - Tallantyre, E

AU - Robertson, N

PY - 2016/9/14

Y1 - 2016/9/14

M3 - Poster

ER -

Willis M, Pearson O, Illés Z, Nielsen C, Mathiesen TS, Duddy M et al. Multiple sclerosis disease rebound after treatment switch from fingolimod to alemtuzumab. 2016. Poster session præsenteret på 32nd ECTRIMS, London, Storbritannien.